What is the reason why Daewoong Pharmaceutical was interested in Hanall Biopharma, followed by Yuhan Corporation?

Followed by Yuhan Corporation which purchased 8.95% of the Hanall Biopharma’s total shares three years ago, Daewoong Pharmaceutical attracted interests of the industry as buying 30.2% of its total shares.

On the 29^th, Daewoong Pharmaceutical invested KRW 104.6 billion funds to secure the total 15.5 million shares (30.2% of the total) including 6 million old shares and 9.5 million new shares th...